The UK has an advantage in conducting clinical trials in that everyone is insured and receives treatment through National Health Services (NHS). The NHS is the largest single healthcare provider in the world. With more than 4,000 life sciences companies in the UK, Great Britain’s life sciences cluster is well-poised to offer this innovative program to Israeli’s bio, pharma, and medical device companies.
Image of the Month
Polymer Based Continuous Offset Printing
Flexible chiral metamaterials.
NSF Center for High-rate Nanomanufacturing and Plastics Engineering, University or Massachusetts Lowell
NSTI Online Community